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Abstract The effect of severity of liver cirrhosis, an
alcoholic and non-alcoholic genesis, on the results of serum
lipids and lipoproteins was evaluated. Serum cholesterol,
triglycerides, high-density lipoprotein cholesterol (HDL-
Ch), and low-density lipoprotein cholesterol (LDL-Ch)
were measured in the sera of 59 patients suffering from
alcoholic cirrhosis and 34 patients with non-alcoholic cir-
rhosis. The level of serum triglycerides depends on the
severity of liver damage in alcoholic liver cirrhosis, being
the highest in Child-Pugh score B. The severity of liver
damage significantly affects the HDL-Ch and LDL-Ch
levels in cirrhosis of non-alcoholic origin, reaching the
highest value for LDL-Ch and the lowest for HDL-Ch in
score C. It should not be generalized that the levels of
lipids and lipoproteins in liver cirrhosis progressively
diminished with the deterioration of liver function. The
serum HDL-Ch and LDL-Ch may be considered as markers
of severity of liver damage in non-alcoholic cirrhosis, but
the triglycerides only in disease of alcoholic origin.
Keywords Lipids and lipoproteins  Severity
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Introduction
The liver plays a crucial role in the synthesis, secretion,
catabolism, and storage of lipids and lipoproteins. There-
fore, the serum lipids and lipoproteins concentrations in
liver diseases could be changed [1–4]. Generally, the level
of plasma lipids and lipoproteins tends to decrease with the
severity of liver disease [5, 6]. However, the results of
these studies were not the same. The reason for the dis-
crepancy of the results could be the different etiology of
liver injury. There is no information if alcoholic and non-
alcoholic liver cirrhosis equally affect the lipids metabo-
lism. It has been known that the major effects of high
alcohol consumption on lipids metabolism are the exces-
sive synthesis of triglycerides, hypertriglyceridemia and
hypercholesterolemia, defective esterification of plasma
cholesterol, and decreased level of high-density lipoprotein
cholesterol [7]. These changes should be contrasted with
the effects produced by moderate alcohol consumption
which can be reversible with cessation of alcohol drinking
[8]. Therefore, the aim of this study was to evaluate the
influence of liver cirrhosis severity, an alcoholic and non-
alcoholic origin, on the concentration of serum lipids and
lipoproteins.
Materials and methods
Studies were carried out on 59 patients suffering from
alcoholic cirrhosis (ALC) (14 females and 45 males) (mean
age: 53 years; range: 28–78) and 34 patients with non-
alcoholic cirrhosis (NALC) (16 females and 18 males)
(mean age: 62 years; range: 20–84) who were admitted in
the Department of Infectious Diseases and Hepatology.
The alcoholic group consisted of alcohol-dependent
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patients. The diagnosis of dependency was made on the
basis of ICD-10 criteria (World Health Organization,
1992). The self-reported mean alcohol consumption was
1,106 g of ethanol per week (range: 553–3,290), and mean
time of dependency was 23 years (range: 10–44). The time
after cessation of drinking was above 1 month. The fol-
lowing numbers of patients were in subgroups with ALC: 7
in score A, 21 in score B, and 26 in score C, and in sub-
groups with NALC: 11 patients in score A, 14 in score B,
and 6 in score C. All patients with cirrhosis were tested for
the prevalence of the hepatitis virus. The causes of non-
alcoholic liver cirrhosis were HBV in 14 patients, HCV in
9 patients, and unidentified factors in the rest patients.
Among unidentified cases, 2 patients had type 2 diabetes
mellitus. Any patient was on previous drug treatment to
lower cholesterol.
The diagnosis of cirrhosis was performed on the basis of
signs and symptoms of the disease, physical and clinical
examination (abdominal ultrasound and liver biopsy in
selected cases), and biochemical liver panel known as liver
function tests which included alanine and aspartate ami-
notransferase (ALT and AST), c-glutamyl transferase (c-
GT), bilirubin, albumin, and total protein. The serological
tests (HBsAg and anti-HCV) were also used to support the
diagnosis of viral infections.
The control group consisted of 80 healthy subjects
recruited from hospital workers (mean age 55 years; range
22–60; 36 females and 44 males). All subjects (healthy and
sick) gave their consent to participate in the studies. Blood
samples were taken fasting morning by vein puncture once
after admittance, before treatment. The blood was allowed
to clot. The sera were separated by centrifugation at
1,5009g for 10 min at room temperature and stored at
-86 C until analysis. This study was approved ethically
by the Bioethical Committee working at the Medical
University in Bialystok (Approval No. R-I-002/192/2009).
All patients provided informed written consent.
Serum cholesterol (Ch), triglycerides (TG), high-density
lipoprotein cholesterol (HDL-Ch) were measured by
methods manufactured by Abbott Diagnostics (Wiesbaden,
Germany) on the Architect c8000 analyzer (Abbott Labo-
ratories, Abbott Park, USA). Low-density lipoprotein
cholesterol (LDL-Ch) was calculated with Friedewald’s
formula.
To test the effect of liver diseases on the concentration
of lipids and lipoproteins, ANOVA rank Kruskal–Wallis
test was performed. Because the chance of finding one or
more significant differences in 3 tested groups was
14.26 % (Bonferroni correction factor), we performed the
nonparametric multiple comparison test (post hoc test for
Kruskal–Wallis) to ascertain which the intermediate
medians are significantly different. The differences
between tested and control groups were evaluated by
Mann–Whitney U test. To calculate the correlation
between variables, Spearman rank correlation coefficient
was used. We considered P values less than 0.05 as sta-
tistically significant.
Results
The concentration of lipids and lipoproteins are presented
in Table 1. The concentration of cholesterol, HDL-cho-
lesterol, and LDL-cholesterol in alcoholic and non-alco-
holic cirrhosis were significantly decreased in comparison
with the control group. The level of triglycerides was
decreased in NALC and was lower than that in alcoholic
ones.
In alcoholic liver cirrhosis, only the level of serum tri-
glycerides appears to be dependent on the severity of liver
damage evaluated by Child-Pugh score (H = 6.676,
P = 0.036) (Fig. 1). The mean TG level in score B
(1.58 ± 0.61 mmol/L) was significantly higher than that in
score A (1.07 ± 0.37 mmol/L; P = 0.049) and score C
(1.40 ± 1.13 mmol/L; P = 0.026). In NALC, both, LDL-
cholesterol and HDL-cholesterol, significantly depend on
the degree of liver damage (H = 9.660, P = 0.008 for LDL-
cholesterol and H = 7.641, P = 0.022 for HDL-choles-
terol) (Fig. 1). Further analysis (post hoc) revealed the sig-
nificant differences between score A (2.02 ± 0.34 mmol/L)
Table 1 Serum lipids and lipoproteins in ALC and NALC
Cholesterol (mmol/L) Triglycerides (mmol/L) HDL-cholesterol (mmol/L) LDL-cholesterol (mmol/L)
Control group 4.98 ± 0.65 1.25 ± 0.37 1.32 ± 0.25 3.04 ± 0.54




















Data are mean ± standard deviation. The differences between tested group and controls were estimated by Mann–Whitney U test, Pk the
differences between tested group and controls, Pa the differences between tested groups
418 Clin Exp Med (2014) 14:417–421
123
and score C (3.04 ± 0.74 mmol/L) (P = 0.034) and
between score B (2.02 ± 0.79 mmol/L) and score C
(P = 0.009) for LDL-cholesterol and between score A
(1.06 ± 0.43 mmol/L) and score C (0.56 ± 0.25 mmol/L)
(P = 0.029) for HDL-cholesterol. The additional compari-
son between cases with viral and non-viral etiology of
disease was made in NALC. Two cases of diabetes were
excluded from the evaluation. These comparisons revealed a
statistical significant differences between viral and non-
viral etiology of NALC only for LDL-cholesterol
(1.77 ± 0.50 mmol/L for viral vs. 2.45 ± 0.79 mmol/L for
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Fig. 1 Serum concentrations of
cholesterol (Ch), triglycerides
(TG), high-density lipoprotein
cholesterol (HDL-Ch) and low-
density lipoprotein cholesterol
(LDL-Ch) in liver cirrhosis. Box
and whiskers plot illustrating the
means, standard errors of mean
(SE) and standard deviations
(SD). A, B, C—Child-Pugh
scores
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glucose concentration in the non-viral group (6.42 ± 2.76
mmol/L) was significantly higher (P = 0.017) than that
in the viral group (4.97 ± 0.91 mmol/L). The correlation
study showed that only HDL-cholesterol correlated with
the severity of liver disease in both, ALC and NALC
(R = -0.407, P = 0.005 and R = -0.464, P = 0.008,
respectively).
Discussion
In general, the plasma lipids and lipoproteins tend to
decrease with parenchymal liver disease, and the level and
composition of the lipoproteins depends on the activity of
enzymes involved in lipid metabolism. These include
lipoprotein lipase (LPL), lecithin-cholesterol acyltransfer-
ase (LCAT), and hepatic triglyceride lipase (HTGL) [4, 9].
The results of this study confirm that the concentrations of
lipids and lipoproteins in the liver diseases are changed [1–
4]. The mean concentrations of cholesterol, HDL-choles-
terol, and LDL-cholesterol were significantly decreased in
liver cirrhosis of both origin (alcoholic and non-alcoholic).
The triglycerides level diminished only in NALC and was
lower than that in alcoholic ones. In circulation, the tri-
glycerides-rich lipoproteins comprise very low-density
lipoprotein (VLDL) and chylomicrons. The assembly and
secretion of VLDL particles take place in the liver cells and
both elements, apolipoprotein B and microsomal triglyc-
eride transfer protein (MTP), are necessary for these pro-
cesses [10]. It has been shown that MTP plays a role in
transferring lipid to nascent apolipoprotein B and hepatic
induction of MTP, resulting in a reduction in hepatic TG
accumulation and improvement of VLDL export, which
increases the serum level of TG [11]. The reason of that
may be the involvement of MTP in the import of triglyc-
erides into the lumen of endoplasmic reticulum.
The evidence showed that cholesterol and its fractions
progressively decrease with increasing severity of the dis-
ease, however, without differentiation in the origin of ill-
ness [2]. In our study, the fractions of cholesterol differ
according to etiology of liver cirrhosis. In non-alcoholic
liver cirrhosis, HDL-cholesterol concentration diminished
with the severity of disease, being lower in severe liver
damage (score C) than that in mild damage (score A). In
contrast, LDL-cholesterol level in severe liver damaged
(score C) was higher than that in less damaged organ (score
A and B). In ALC, only the level of triglycerides changes
with the severity of liver damage (according to the analysis
of variance), although, the level of TG was not highest in
score C, but in score B. Class C is considered as decom-
pensated disease (with severe ascites and encephalopathy),
in which the ability of the liver to synthesize and b-oxi-
dation of fatty acids, and to synthesis of TG, is reduced.
Ramcharran and co-workers [12] have found that more
severe liver disease is associated with lower lipid levels,
with the exception of TG levels that is directly related to
steatosis. Therefore, it could not be generalized that the
levels of lipids and lipoproteins in liver cirrhosis progres-
sively diminished with the deterioration of liver status. The
decreased HDL-cholesterol and LDL-cholesterol levels in
liver cirrhosis might be explained by the decreased syn-
thesis of apolipoproteins A and B [13]. The level of apo-
lipoprotein A-1 was found to be low in cirrhosis, and its
value was higher in Child-Pugh A group than that in Child-
Pugh B and C groups. Therefore, apolipoprotein A-1 was
recommended the most affected lipid parameters in liver
injury among lipids [6]. Habib et al. [14] proposed that
decline in lipoprotein cholesterol may reflect deterioration
in liver function and of the lipoproteins, the HDL-choles-
terol is the best liver function test and predictor of survival
in cirrhotic patients.
Many data showed that chronic liver diseases strongly
impair the lipid metabolism with the hypocholesterolemia
as a common finding in cirrhosis and viral hepatitis [15,
16]. Additionally, the lower level of serum lipids is
associated with more severe disease. In patients with
chronic hepatitis C, lipid parameters were significantly
lower in those with fibrosis than in those without fibrosis
[12], and grading score was positively correlated with total
cholesterol and LDL-cholesterol [17]. In patients with
HCV, the lipogenesis is elevated while cholesterol syn-
thesis is impaired [18]. Viral liver cirrhosis (HCV and
HBV) also dysregulated the host lipid metabolism. How-
ever, there were many differences in lipid values between
HCV and HBV cirrhosis [16]. In patients with cirrhosis,
total serum cholesterol, LDL, and HDL-cholesterol were
lower than that in patients with chronic active hepatitis
[2]. Our study revealed that LDL-cholesterol was lower in
viral etiology of cirrhosis than that in non-viral. We can
speculate that the non-viral etiology of cirrhosis may be
the metabolic syndrome. For this purpose, we tested the
glucose level and denoted that its level in non-viral group
was higher than that in viral one. This would confirm the
metabolic etiology of non-viral cirrhosis, it means insulin
resistance, which can develop into non-alcoholic steato-
hepatitis (NASH).
We conclude that it should not be generalized that the
levels of lipids and lipoproteins in liver cirrhosis progres-
sively diminished with the deterioration of liver function.
On the basis of our results, the serum HDL-cholesterol and
LDL-cholesterol may be considered as markers of the
severity of liver damage only in NALC, but the triglycer-
ides in cirrhosis of alcoholic origin.
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